Showing 2571-2580 of 21408 results for "".
- Long COVID: Persistent Cardiac and Pulmonary Inflammation Riskshttps://reachmd.com/news/long-covid-persistent-cardiac-and-pulmonary-inflammation-risks/2474587/Long COVID presents significant challenges by uncovering complications that extend well beyond the acute phase of SARS-CoV-2 infection. A growing body of research reveals that some patients continue to experience persistent inflammation in heart and lung tissues fo
- AI in Medical Imaging: Facial Analysis for Biological Age Estimation and Cancer Prognosishttps://reachmd.com/news/ai-in-medical-imaging-facial-analysis-for-biological-age-estimation-and-cancer-prognosis/2474582/AI in Medical Imaging: Facial Analysis for Biological Age Estimation and Cancer Prognosis Unveiling the Future of Oncology with AI-Driven Facial Analysis The advent of FaceAge, an advanced deep learning tool from researchers at Mass General Brigham, marks
- Assessing the Impact of Epidural Analgesia on Postpartum Hemorrhage in High-Risk Obstetric Populationshttps://reachmd.com/news/epidural-analgesia-and-postpartum-hemorrhage-risk-in-gestational-hypertension/2474513/As the prevalence of hypertensive disorders in pregnancy continues to climb, understanding the safety profile of epidural labor analgesia (ELA) in high-risk obstetric populations has become increasingly important. Recent retrospective data challenge longstanding co
- Gut Microbiota and Multiple Sclerosis: Insights from Twin Studieshttps://reachmd.com/news/gut-microbiota-and-multiple-sclerosis-insights-from-twin-studies/2474566/Recent advancements in neurology have revealed that the interaction between gut microbiota and the immune system may significantly impact the onset and progression of multiple sclerosis (MS). Twin studies, due to their consistent genetic profiles, offer solid evide
- Fermentation Breakthrough Offers Sustainable Alternative to Myo-Inositol Sourcinghttps://reachmd.com/news/fermentation-breakthrough-offers-sustainable-alternative-to-myo-inositol-sourcing/2474572/A new fermentation-based approach to producing myo-inositol, introduced by DMC Biotechnologies, may reshape how this essential nutrient is manufactured and delivered to health and wellness markets. As demand grows for sustainable and transparent ingredient sourcing, DMC’s method offers a cleaner,
- Unveiling Genetic and Molecular Pathways in Parkinson's Disease: Emerging Insightshttps://reachmd.com/news/unveiling-genetic-and-molecular-pathways-in-parkinsons-disease-emerging-insights/2474564/Recent research is shedding light on the intricate genetic and molecular mechanisms underlying Parkinson's Disease (PD), revealing how specific gene variants and RNA editing processes influence disease progression and symptomatology. P
- Revolutionizing Oncology Imaging: From Liver Cancer to Neuroblastomahttps://reachmd.com/news/revolutionizing-oncology-imaging-from-liver-cancer-to-neuroblastoma/2474555/Emerging imaging technologies are reshaping the landscape of oncology, particularly in the management of liver cancer and neuroblastoma. Innovations such as diffusion kurtosis imaging and artificial intelligence (AI) are enhancing diagnostic precision and prognostic assessments,
- Harnessing Technology for COVID-19 Forecasting and Public Health Interventionshttps://reachmd.com/news/harnessing-technology-for-covid-19-forecasting-and-public-health-interventions/2474548/Recent studies reveal that analyzing foot traffic data from mobile devices can significantly enhance neighborhood-level COVID-19 forecasts, offering a novel approach to predicting virus spread and improving targeted public health intervention
- Innovative Approaches in Breast Cancer Management: From Neoadjuvant Therapy to Advanced Therapeuticshttps://reachmd.com/news/innovative-approaches-in-breast-cancer-management-from-neoadjuvant-therapy-to-advanced-therapeutics/2474551/Recent advancements in breast cancer treatment are reshaping clinical practices, particularly in optimizing surgical decisions post-neoadjuvant therapy and introducing advanced therapeutics for treatment-resistant cases. Neoadjuvant th
- CRISPR Gene-Editing in GI Cancer: A Turning Point in Immunotherapyhttps://reachmd.com/news/crispr-gene-editing-in-gi-cancer-a-turning-point-in-immunotherapy/2474558/In the realm of gastrointestinal (GI) oncology, a groundbreaking clinical trial has demonstrated the potential of CRISPR/Cas9 gene-editing to enhance immune responses against advanced cancers. Conducted by the University of Minnesota, this study marks a pivotal moment in the int